Progress Toward Poliomyelitis Eradication - Afghanistan, January 2017-May 2018

MMWR Morb Mortal Wkly Rep. 2018 Aug 3;67(30):833-837. doi: 10.15585/mmwr.mm6730a6.

Abstract

Afghanistan, Pakistan, and Nigeria remain the only countries where transmission of endemic wild poliovirus type 1 (WPV1) continues (1). This report describes polio eradication activities, progress, and challenges to eradication in Afghanistan during January 2017-May 2018 and updates previous reports (2, 3). Fourteen WPV1 cases were confirmed in Afghanistan in 2017, compared with 13 in 2016; during January-May 2018, eight WPV1 cases were reported, twice the number reported during January-May 2017. To supplement surveillance for acute flaccid paralysis (AFP) and laboratory testing of stool samples, environmental surveillance (testing of sewage samples) was initiated in 2013 and includes 20 sites, 15 of which have detected WPV1 circulation. The number of polio-affected districts increased from six in 2016 to 14 in 2017 (including WPV1 cases and positive environmental samples). Access to children for supplementary immunization activities (SIAs) (mass campaigns targeting children aged <5 years with oral poliovirus vaccine [OPV], regardless of vaccination history), which improved during 2016 to early 2018, worsened in May 2018 in security-challenged areas of the southern and eastern regions. To achieve WPV1 eradication, measures to maintain and regain access for SIAs in security-challenged areas, strengthen oversight of SIAs in accessible areas to reduce the number of missed children, and coordinate with authorities in Pakistan to track and vaccinate mobile populations at high risk in their shared transit corridors must continue.

MeSH terms

  • Adolescent
  • Afghanistan / epidemiology
  • Child
  • Child, Preschool
  • Disease Eradication*
  • Humans
  • Immunization Programs
  • Immunization Schedule
  • Infant
  • Poliomyelitis / epidemiology
  • Poliomyelitis / prevention & control*
  • Poliovirus / isolation & purification
  • Poliovirus Vaccine, Oral / administration & dosage
  • Population Surveillance*
  • Vaccination / statistics & numerical data

Substances

  • Poliovirus Vaccine, Oral